107 related articles for article (PubMed ID: 12843828)
1. [Adverse cutaneous reaction to celecoxib: 6 cases].
Murr D; Bocquet H; Lelouet H; Fischer RM; Revuz J; Cosnes A
Ann Dermatol Venereol; 2003 May; 130(5):519-21. PubMed ID: 12843828
[TBL] [Abstract][Full Text] [Related]
2. [Severe cutaneous drug reactions to celecoxib (Celebrex)].
Marquès S; Milpied B; Foulc P; Barbarot S; Cassagnau E; Stalder JF
Ann Dermatol Venereol; 2003 Nov; 130(11):1051-5. PubMed ID: 14724542
[TBL] [Abstract][Full Text] [Related]
3. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
[TBL] [Abstract][Full Text] [Related]
4. [Celecoxib induced toxiderma with positive patch-test].
Verbeiren S; Morant C; Charlanne H; Ajebbar K; Caron J; Modiano P
Ann Dermatol Venereol; 2002 Feb; 129(2):203-5. PubMed ID: 11937958
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
Wolfe F; Zhao S; Pettitt D
J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
[TBL] [Abstract][Full Text] [Related]
6. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.
Soni P; Shell B; Cawkwell G; Li C; Ma H
Curr Med Res Opin; 2009 Aug; 25(8):1841-51. PubMed ID: 19530981
[TBL] [Abstract][Full Text] [Related]
7. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.
Solomon DH; Schneeweiss S; Glynn RJ; Kiyota Y; Levin R; Mogun H; Avorn J
Circulation; 2004 May; 109(17):2068-73. PubMed ID: 15096449
[TBL] [Abstract][Full Text] [Related]
8. [Cutaneous changes occurring after taking non-steroidal anti-inflammatory drugs--five-years' retrospective studies].
Wojas-Pelc A; Setkowicz M; Kiełtyka A; Bogdaszewska-Czabanowska J
Przegl Lek; 2002; 59(12):968-72. PubMed ID: 12731368
[TBL] [Abstract][Full Text] [Related]
9. Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective cohort study.
Rahme E; Bardou M; Dasgupta K; Toubouti Y; Ghosn J; Barkun AN
Rheumatology (Oxford); 2007 Feb; 46(2):265-72. PubMed ID: 16844699
[TBL] [Abstract][Full Text] [Related]
10. Effects of celecoxib on volumes of hematoma and edema in patients with primary intracerebral hemorrhage.
Park HK; Lee SH; Chu K; Roh JK
J Neurol Sci; 2009 Apr; 279(1-2):43-6. PubMed ID: 19168192
[TBL] [Abstract][Full Text] [Related]
11. Anaphylaxis to celecoxib.
Levy MB; Fink JN
Ann Allergy Asthma Immunol; 2001 Jul; 87(1):72-3. PubMed ID: 11476468
[TBL] [Abstract][Full Text] [Related]
12. New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study.
Wang J; Mullins CD; Mamdani M; Rublee DA; Shaya FT
Ann Pharmacother; 2007 Jun; 41(6):937-43. PubMed ID: 17488830
[TBL] [Abstract][Full Text] [Related]
13. Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
Goldstein JL; Zhao SZ; Burke TA; Palmer R; von Allmen H; Henderson SC
Am J Gastroenterol; 2003 Dec; 98(12):2627-34. PubMed ID: 14687808
[TBL] [Abstract][Full Text] [Related]
14. Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib?
Rahme E; Barkun AN; Toubouti Y; Scalera A; Rochon S; Lelorier J
Arthritis Rheum; 2007 Jun; 57(5):748-55. PubMed ID: 17530673
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with celecoxib and rofecoxib utilization.
Rawson NS; Nourjah P; Grosser SC; Graham DJ
Ann Pharmacother; 2005 Apr; 39(4):597-602. PubMed ID: 15755796
[TBL] [Abstract][Full Text] [Related]
16. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
Daniels S; Robbins J; West CR; Nemeth MA
Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
19. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study.
Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib compared with sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials.
Yelland MJ; Nikles CJ; McNairn N; Del Mar CB; Schluter PJ; Brown RM
Rheumatology (Oxford); 2007 Jan; 46(1):135-40. PubMed ID: 16777855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
